Análisis de la cuota de mercado y oportunidades de los inhibidores de la neuraminidasa (2025-2031)
Neuraminidase Inhibitors Drug Market Report Analysis
Neuraminidase Inhibitors Drug Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- GLAXOSMITHKLINE PLC
- GILEAD SCIENCES
- DAIICHI SANKYO
- BIOCRYST LTD
- F. HOFFMANN LA ROCHE
- FOREST PHARMACEUTICALS INC.
- ENDO PHARMACEUTICALS INC.
- BRITANNICA
- SHIONOGI CO
Regional Overview
- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
- Medio Oriente y África
Market Segmentation
By Tipo de fármaco
- oseltamivir
- zanamivir
- peramivir
- laninamivir
By Vía de administración
- parenteral
- nasal y oral
By Canal de Distribución
- Farmacia Hospitalaria
- Farmacia Minorista
- Farmacia Online
- Otros
By Geografía
- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
Get Free Sample For